Anthony Fauci

Vaccine for prevention of HIV discovered From Our Reporter -25.09.2009 FOR the first time, an experimental vaccine has prevented infection with the HIV virus, a watershed event in the deadly epidemic and a surprising result. Recent failures led many scientists to think such a vaccine might never be possible. The vaccine cut the risk of becoming infected with HIV by more than 31 per cent in the world’s largest AIDS vaccine trial of more than 16,000 volunteers in Thailand, researchers announced on Thursday in Bangkok. Even though the benefit is modest, “it’s the first evidence that we could have a safe and effective preventive ... Read Full Story

From Genetic Engineering & Biotechnology News: In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection. “These new findings represent an important step forward in HIV vaccine research,” says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious ... Read Full Story

In a breakthrough, researchers have for the first time have found a vaccine that cuts HIV infection by more than 31 per cent, giving fresh boost to the global fight against the dreaded disease. The experimental drug cuts the risk of HIV infection by a third in the world’s largest AIDS trial of more than 16,000 volunteers in Thailand, researchers said. It is the first time after two decades of human trials that a vaccine has stopped the virus infecting 7,500 across the world every day. “It gives me cautious optimism about the possibility of improving this result and developing a more effective AIDS ... Read Full Story

Vaccine for prevention of HIV discovered From Our Reporter -25.09.2009 FOR the first time, an experimental vaccine has prevented infection with the HIV virus, a watershed event in the deadly epidemic and a surprising result. Recent failures led many scientists to think such a vaccine might never be possible. The vaccine cut the risk of becoming infected with HIV by more than 31 per cent in the world’s largest AIDS vaccine trial of more than 16,000 volunteers in Thailand, researchers announced on Thursday in Bangkok. Even though the benefit is modest, “it’s the first evidence that we could have a safe and effective preventive ... Read Full Story

Medical history was made on Thursday when two U.N. agencies stated that promising results with an experimental new AIDS vaccine offered new hope in the battle against HIV, but more tests still need to be done. The new HIV vaccine tested on volunteers is a mixture of Sanofi-Aventis’s ALVAC canary pox vaccine and the failed HIV vaccine AIDSVAX , made by VaxGen and now managed by the Global Solutions for Infectious Diseases, a non-profit organization. from the official NIH announcement : “These new findings represent an important step forward in HIV vaccine research,” says Anthony S. Fauci, M.D., director of the National Institute of ... Read Full Story